MRK
MRK
NYSE · Pharmaceuticals

Merck & Co. Inc.

S&P 500 Dow Jones Mega-Cap Stocks Blue Chip Stocks Pharmaceutical Stocks Healthcare Stocks Best Dividend Stocks
$146.94
-3.42 (-2.27%)
As of Nov 5, 9:30 PM ET ·
Analyst Consensus
Buy
35
Analysts
Very High
Coverage
Buy 26 74%
Hold 9 26%
Sell 0 0%
Price Target
Analyst Price Target +8.4% upside
Low Target $113.44
Average Target $159.27
High Target $183.82
Current Price $146.94
Current
$146.94
Target
$159.27
$113.44 $159.27 avg $183.82
Scenario Analysis
Bear Case
$113.44
-22.8%
Low target
Base Case
$159.27
+8.4%
Avg target
Bull Case
$183.82
+25.1%
High target
Risk/Reward
1.1x
Balanced
Price in Context
52-Week High
$156.92
-6.4% from high
52-Week Low
$82.01
+79.2% from low
50-Day SMA
$146.54
+0.3% vs SMA
200-Day SMA
$127.28
+15.4% vs SMA
RSI (14)
56.5
Neutral
Target vs 52W High
$159.27
+1.5% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 36 86% $1,330.33 -2.5%
RDY
Dr. Reddy's Laboratories
 Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
 Buy 30 73% $299.55 +10.0%
MRK
Merck & Co. Inc.
 Buy 35 74% $159.27 +8.4%
PFE
Pfizer Inc.
 Hold 33 39% $33.90 +13.5%
BMY
Bristol-Myers Squibb Co
 Hold 34 44% $174.50 +176.4%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 14 93% $36.26 -46.3%
ZTS
Zoetis Inc
 Hold 23 48% $209.87 +155.6%